CareClarity Business Case & Commercialisation Strategy
How CareClarity generates revenue, scales to patients and becomes a sustainable healthcare product
One-line business case CareClarity solves a £1.9 billion problem — NHS missed appointments driven by patients not understanding their letters — with a zero-friction AI tool that can be monetised through three parallel revenue streams: a patient freemium subscription, NHS Trust B2B licensing, and a developer API. Each stream is independent, each validates the others, and together they build a defensible healthcare product business.
- The Business Problem Worth Solving Before any revenue model works, the problem must be large enough and painful enough to justify a product business. CareClarity passes both tests.
£1.9Bn annual cost of missed NHS hospital appointments (2024) 43% of UK adults cannot understand written health information 11.8M hospital appointments missed in the UK in 2024 £102M spent by NHS on postal letters in 2024 alone
The core business insight is this: patients who cannot understand their NHS letter are patients who miss appointments, make unnecessary calls to admin teams, and disengage from their own care. CareClarity turns letter confusion into letter confidence — and that conversion has measurable value for patients, NHS Trusts, and the wider health system.
Why this is a product business, not just a hackathon project The NHS is actively spending money trying to solve this problem — £102 million on postal letters, growing NHS App infrastructure, and an explicit operational target to reduce DNA (Did Not Attend) rates in 2025/26. That spending represents a market willing to pay for a better solution. CareClarity does not need to create demand. It needs to capture demand that already exists.
- Business Model Overview CareClarity operates a three-layer business model. Each layer addresses a different customer segment, operates independently, and reinforces the others. The model is designed to generate revenue from day one at the individual level while building toward higher-value institutional contracts.
Layer Customer Revenue Type Timeline Layer 1 Individual patients (B2C) Freemium subscription Month 1+ Layer 2 NHS Trusts and healthcare organisations (B2B) SaaS licence per trust Month 6+ Layer 3 Developers and health platforms (B2D) API usage billing Month 9+
Design principle The free tier is not a loss leader — it is the distribution strategy. Every patient who uses CareClarity for free and finds value becomes a case study, a referral source, and a data point that proves adoption before a Trust procurement conversation. The freemium model funds itself through the premium tier while building the B2B sales funnel organically.
- Revenue Streams in Detail 3.1 Patient Freemium — Direct-to-Consumer
Stream 1 Patient Subscription — Direct-to-Consumer (B2C) Revenue Model Freemium with premium tier. Free tier provides core letter understanding (plain-English summary, action checklist, missing-detail flags). Premium unlocks advanced features.
Price Point Free tier: £0. Premium: £3.99/month or £29.99/year (less than one NHS prescription charge).
Target Volume Target: 10,000 free users in Year 1. Conversion rate target: 8% to premium = 800 paying users.
Estimated Monthly Revenue 800 users x £3.99 = ~£3,190/month (~£38,300/year at Year 1 scale).
Why It Works NHS patients are already motivated — they have a confusing letter in their hand. Zero friction (no login required for free tier) maximises top-of-funnel. Price is below psychological resistance threshold (less than a coffee per month). Annual plan reduces churn.
Free vs Premium Feature Split
Feature Free Tier Premium Tier Plain-English letter summary Yes — full Yes — full Action checklist Yes — full Yes — full Missing/unclear detail flags Yes — full Yes — full Appointment Readiness Pack Yes — basic version Yes — full version Trusted family/carer summary TXT download only TXT + PDF, branded Letter comparison (What Changed?) One comparison per month Unlimited comparisons Multilingual translation 3 languages All 13 languages Prescription Admin Helper No Yes NHS App Navigation Helper No Yes Explain this sentence 3 uses per month Unlimited Product-support chatbox English only All supported languages Accessibility Mode Yes — full Yes — full History / saved letters No (by design — privacy) Optional encrypted vault Priority AI processing Standard speed Priority queue
3.2 NHS Trust B2B — Institutional Licensing
Stream 2 NHS Trust Licence — Business-to-Business (B2B) Revenue Model Annual SaaS licence sold to NHS Trusts, ICBs (Integrated Care Boards) and NHS-funded community organisations. CareClarity is deployed as a white-label companion to existing trust patient portals (DrDoctor, Patients Know Best) or embedded in the NHS App experience.
Price Point Small Trust (under 200k patients): £12,000/year. Medium Trust (200k–500k patients): £28,000/year. Large Trust (500k+ patients): £55,000/year. ICB or multi-trust deployment: £90,000–£150,000/year.
Target Volume Year 1: 2 pilot Trusts (at heavily discounted pilot rate of £5,000 each). Year 2: 8 Trusts. Year 3: 25 Trusts.
Estimated Monthly Revenue Year 1 (pilot): £10,000. Year 2: ~£224,000. Year 3: ~£700,000+ (mix of Trust sizes).
Why It Works NHS Trusts have a direct financial incentive: each 1% reduction in DNA rates across a medium Trust saves approximately £960,000 annually (based on £160 per missed appointment x 6,000 avoidable DNAs). CareClarity's annual licence costs less than the value of preventing 200 missed appointments. The ROI case for procurement writes itself.
B2B Sales Strategy — How to Win Trust Contracts NHS procurement is slow. The strategy is to shortcut it:
- Start with NHS charity and voluntary sector partnerships — Age UK, Healthwatch England, Carers UK, and local patient groups can distribute CareClarity to their members immediately without procurement. This builds evidence.
- Use direct-to-patient adoption data as a proof of value conversation opener with Trust digital leads and Chief Digital Information Officers (CDIOs). 'Our tool has been used 10,000 times by patients at your Trust' is a compelling cold outreach message.
- Apply to NHS Innovation Accelerator (NIA) and AHSN (Academic Health Science Network) programmes — these provide both credibility and direct access to NHS decision-makers.
- Position alongside existing DrDoctor deployments as a complementary layer, not a competing product — this removes the procurement objection that CareClarity requires system integration.
- Use the NHS AI Procurement Framework (£900M framework launched May 2026) as the commercial vehicle once registered as a supplier.
3.3 Developer API — Business-to-Developer (B2D)
Stream 3 CareClarity API — Business-to-Developer (B2D) Revenue Model Usage-based API billing. Developers and health platforms pay per API call to access CareClarity's NHS admin letter analysis, plain-English translation, action checklist generation and safety validation layer — without building these capabilities themselves.
Price Point Free tier: 500 API calls/month (for developers and small startups). Starter: £29/month for 5,000 calls. Growth: £99/month for 25,000 calls. Enterprise: custom pricing for NHS tech vendors and digital health platforms.
Target Volume Year 1: 20 developer accounts (free + paid). Year 2: 150 accounts. Year 3: 500+ accounts including first enterprise contract.
Estimated Monthly Revenue Year 1: ~£1,500/month from paid developer accounts. Year 2: ~£12,000/month. Year 3: ~£40,000+/month with first enterprise client.
Why It Works Following the Patiently AI model (which offers a B2B API for EHR integration), there is a proven market for pluggable plain-language health communication APIs. GP software vendors, pharmacy management systems, community health apps and digital care coordination platforms all need this capability but cannot build it themselves. CareClarity's API offers pre-built NHS context-awareness, safety validation and multilingual support — a full solution, not just an LLM wrapper.
- Revenue Projections — Three-Year Model These projections are conservative and based on comparable healthtech products at similar stages. They assume no external funding in Year 1 and modest growth thereafter.
Revenue Stream Year 1 Year 2 Year 3 Patient Subscriptions (B2C) £38,000 £120,000 £360,000 NHS Trust Licences (B2B) £10,000 £224,000 £700,000 Developer API (B2D) £18,000 £144,000 £480,000 TOTAL £66,000 £488,000 £1,540,000
Conservative assumptions Year 1 patient conversion rate: 8% of free users to premium (industry average for healthcare freemium is 5-12%). Year 1 Trust contracts: 2 pilots only. Year 1 API: 20 developer accounts with 40% on paid plans. No grant funding assumed. No NHS Innovation Accelerator placement assumed. If any of these additional revenue sources materialise, Year 1 revenue could be 2-3x higher.
- Go-To-Market Strategy 5.1 Patient Acquisition — How to Reach Individual Users The challenge with direct-to-patient health tools is that users only need them in a specific moment: when they receive a confusing letter. CareClarity's distribution strategy is designed around that moment.
Channel 1 — Search (Organic) When a patient receives a confusing NHS letter, their first action is to search Google. Search terms like 'what does NHS referral letter mean', 'how to understand NHS appointment letter' and 'NHS waiting list letter explained' collectively receive thousands of searches per month in the UK. A focused SEO strategy targeting these intent keywords places CareClarity exactly where the need arises. Channel 2 — Patient Charity Partnerships Age UK serves 8+ million older people. Carers UK has 5.7 million unpaid carers. Mencap supports people with learning disabilities who find NHS letters especially hard to understand. Mind supports mental health patients. Each charity has newsletters, websites and support networks that reach exactly the patients CareClarity helps. Partnership distribution — putting a CareClarity link in a charity's 'understanding your NHS letter' guidance — costs nothing and reaches a highly motivated audience. Channel 3 — GP Surgery and Pharmacy Referral GP surgeries and community pharmacies regularly encounter patients confused by referral letters, appointment notices and prescription admin communications. A simple leaflet or QR code in waiting rooms and at pharmacy counters — 'Confused by your NHS letter? Try CareClarity' — is a zero-cost distribution channel that reaches patients at exactly the right moment of need. Channel 4 — NHS Staff Word of Mouth NHS admin staff, ward clerks and appointment booking teams currently spend significant time on the phone explaining letters to confused patients. If CareClarity can reduce even a portion of those calls, frontline NHS staff have a personal incentive to recommend it. 'Just paste your letter into CareClarity before calling us' becomes a self-service deflection tool that benefits everyone. Channel 5 — Multilingual Community Outreach CareClarity's 13-language support creates a natural entry point into the UK's South Asian, Arabic-speaking, Polish and Eastern European communities — all of which are significantly underserved by existing NHS digital tools. Community language media, mosque and temple noticeboards, and diaspora community organisations offer low-cost, high-trust distribution channels.
5.2 B2B Acquisition — How to Win NHS Trust Contracts NHS procurement requires a different strategy from consumer marketing. The path is: evidence first, conversation second, contract third.
Phase 1 Months 1–6 Build Evidence Without Procurement • Deploy full product on Vercel/Netlify — live and usable by any UK patient • Partner with 2–3 patient charities to distribute CareClarity to their members • Collect anonymised usage data: number of letters processed, most common missing details, most common letter types • Collect qualitative feedback from real patients (survey after each session) • Build the case study library: 'CareClarity processed 50,000 appointment letters in 6 months'
Phase 2 Months 6–12 Enter the NHS Ecosystem • Apply to NHS Innovation Accelerator (NIA) — provides credibility, network access and sometimes funding • Apply to AHSN Innovation Exchange — connects to NHS Trusts actively looking for digital health solutions • Approach 5 NHS Trust CDIOs (Chief Digital Information Officers) with usage data and ROI case • Register on NHS Supply Chain and the NHS AI Procurement Framework (£900M framework, live May 2026) • Approach DrDoctor and Patients Know Best as integration partners — offer CareClarity as a value-add layer • Apply for NHS Digital Health Accelerator funding (available to tools that improve patient communication)
Phase 3 Months 12–36 Scale and Institutionalise • Convert 2 pilot Trusts to full annual contracts • Approach ICBs (Integrated Care Boards) for multi-Trust deployments — one contract covers multiple Trusts • Pursue MHRA Class I registration (following Patiently AI model) to strengthen procurement credibility • Explore NHS App integration through NHS England Digital partnership programme • Launch API programme to enable digital health platforms to embed CareClarity capability • Explore international expansion to NHS-adjacent healthcare systems (Republic of Ireland, Canada, Australia)
- Unit Economics — Does the Business Make Sense? 6.1 Cost to Serve The primary variable cost is AI API usage (Z.AI GLM calls). All other costs are fixed infrastructure.
Cost Item Estimate Notes Z.AI API cost per letter analysis ~£0.01–0.03 Depends on letter length. Average NHS appointment letter ~500 tokens Z.AI API cost per translation ~£0.01–0.02 Per language per letter Z.AI safety validation call ~£0.005 Short classification call Total AI cost per free user session ~£0.03–0.06 Typically one letter, one language, one safety check Total AI cost per premium user/month ~£0.20–0.50 Higher usage: comparisons, multiple languages, prescription helper Infrastructure (Vercel/Netlify) ~£50–200/month Fixed cost until scale Domain, SSL, monitoring ~£30/month Fixed
6.2 Contribution Margin At £3.99/month premium subscription with £0.35 average AI cost per premium user:
Revenue per premium user: £3.99/month AI cost per premium user: ~£0.35/month Gross margin per user: £3.64/month (91% gross margin) At 800 premium users: £3,192 revenue, £280 AI costs, £2,912 gross profit per month. At 5,000 premium users: £19,950 revenue, £1,750 AI costs, £18,200 gross profit per month.
Why the unit economics are exceptional 91% gross margin is typical for pure SaaS businesses. CareClarity achieves this because the product is a software wrapper around AI APIs with no physical costs, no clinical staff, no regulatory manufacturing requirements, and no per-user support overhead (the product-support chatbox is also AI-powered). The main cost risk is AI API price changes — mitigated by multi-provider architecture and the ability to switch models without user-facing changes.
Funding Strategy 7.1 Phase 1 — Bootstrapped Launch (£0 external funding needed) CareClarity can launch and reach its first 10,000 users without external funding. The product is already built. Deployment on Vercel costs under £100/month. Patient acquisition through SEO and charity partnerships costs time, not money. This is a genuine zero-budget launch. 7.2 Phase 2 — Grant Funding (£50,000–£150,000 target) Multiple non-dilutive grant sources are directly applicable: • NHS England Innovation Funding — specifically targeted at digital tools that improve patient communication and reduce health inequalities • Innovate UK Smart Grants — available to health tech startups with a working prototype and evidence of need • NIHR (National Institute for Health and Care Research) — funds health technology evaluation and patient-facing digital tools • Healthtech Innovation Challenge grants — multiple charitable and government funds supporting UK health tech • UKRI Digital Health funding — targets exactly the intersection of AI and patient-facing health administration Grant funding at this stage is non-dilutive, builds credibility with NHS procurement, and often comes with AHSN or NHS partner support that accelerates the B2B sales cycle. 7.3 Phase 3 — Seed Investment (£300,000–£800,000) At the point of first Trust contract and 2,000+ premium subscribers, CareClarity is fundable by health-focused seed investors. The investment case is straightforward: • Proven patient adoption at scale • First recurring B2B revenue from NHS customer • 91% gross margin SaaS model • £1.9Bn addressable problem with NHS policy tailwind • No clinical liability (admin-only boundary) — significantly lower regulatory risk than diagnostic AI • Comparable company Patiently AI operates in 90+ countries — validates global expansion potential
Risks and Mitigations
Risk Likelihood Impact Mitigation NHS procurement is slow — B2B revenue delayed beyond Year 1 High Medium B2C subscription and API revenue are independent. Delay in B2B does not kill the business — it just extends the runway required before B2B contribution. Z.AI API pricing increases significantly Medium Medium Multi-model architecture means switching to an alternative provider (OpenAI, Anthropic, Google) is an engineering task, not a product redesign. Pricing risk is passed to users only if costs increase beyond 3x. NHS App builds native letter comprehension Low High Even if the NHS App adds basic plain-English translation, CareClarity's carer summary, missing-detail flags, letter comparison, prescription admin helper and multilingual workflow are features the NHS App cannot build quickly. The B2B API model also allows CareClarity to power the NHS App rather than compete with it. Patient reluctance to paste healthcare letters into a third-party tool Medium Medium No-login, no-storage architecture directly addresses this. All marketing explicitly states 'your letter is never saved.' Accessibility and trust messaging is built into every screen. NHS staff word-of-mouth referrals build trust faster than ads. Regulatory classification as a medical device Low High CareClarity's admin-only boundary is specifically designed to stay below MHRA Class I/IIa thresholds. By explicitly not interpreting clinical results or making care recommendations, it follows the Patiently AI model which has achieved MHRA Class I registration. Legal review at pre-Series A stage. Strong competitor enters (NHS-funded or Big Tech) Low High NHS-funded tools move slowly and rarely build consumer-grade UX. Big Tech tools (Microsoft, Google) focus on clinical AI, not patient admin. CareClarity's 18-month head start, NHS context training, and carer-focused features create a moat that takes longer to replicate than it appears.
- Why CareClarity Becomes a Successful Product A product becomes successful when it has three things working at the same time: a real problem, the right timing, and a business model that matches the distribution. CareClarity has all three.
The Problem Is Real and Urgent 43% of UK adults struggle to understand their NHS letters. 11.8 million appointments were missed in 2024. The NHS has explicitly named health literacy improvement as an operational priority for 2025/26. This is not a niche problem — it is one of the most common, most costly and most underserved problems in UK healthcare.
The Timing Is Right The NHS is digitising letter delivery through the NHS App (270 million messages projected in 2025). Letters are moving from paper to digital — but the language inside them has not changed. CareClarity enters exactly when the delivery channel is being modernised but the comprehension problem is getting worse, not better. Every NHS Trust implementing DrDoctor or Patients Know Best is a potential CareClarity partner.
The Business Model Matches the Distribution Zero friction (no login for free tier) maximises top-of-funnel. Freemium converts users who see consistent value. B2B licensing converts the NHS institutions that benefit financially from reduced DNAs. The API monetises the developer ecosystem that needs NHS context-aware AI. Each layer funds the next. Each layer validates the others. The business does not depend on any single revenue stream succeeding.
The Safety Boundary Is the Moat Healthcare AI products fail in three ways: they give dangerous advice, they create liability for the organisations using them, or they lose patient trust. CareClarity is architecturally designed to avoid all three. The admin-only boundary, enforced at the AI layer through Z.AI safety validation, means CareClarity can be recommended by NHS staff, adopted by NHS Trusts, and used by patients without any of the clinical governance overhead that kills healthcare AI procurement. That boundary is not a limitation — it is the product's most commercially valuable feature.
- Summary — The Investment Case in Four Numbers
£1.9Bn problem size (NHS DNA cost, 2024) 91% gross margin at premium scale £1.54M projected Year 3 total revenue £0 external funding needed to launch
The one-sentence investment case CareClarity is a 91%-margin SaaS product that turns a £1.9 billion NHS problem into a three-stream revenue business — direct-to-patient subscription, NHS Trust licensing, and developer API — that can launch today for zero capital and scale to seven-figure revenue within three years.
CareClarity — Team Eleven — Vibehack London 2026 · Produced June 2026
Log in or sign up for Devpost to join the conversation.